Updated on 20 January 2026
Collaboration: multiomics of the tumor microenvironment
Researcher at Istituto Tumori 'Giovanni Paolo II'
Bari, Italy
About
Our laboratory offers access to a state-of-the-art spatial proteomics platform enabling high-dimensional mapping of protein expression and cellular interactions within tumor tissues.
We are seeking partners with expertise in:
-
Computational biology and AI/machine learning for spatial data analysis and pattern recognition
-
Multiomics integration (transcriptomics, genomics, metabolomics) with spatial proteomics
-
Translational and clinical oncology with access to well-annotated patient cohorts or preclinical models
Our aim is to contribute advanced spatial proteomics capabilities to collaborative projects that dissect TME heterogeneity and identify biomarkers or therapeutic targets for precision oncology.
Topic
- DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-03: Integrating New Approach Methodologies (NAMs) to advance biomedical research and regulatory testing
- DESTINATION 6: HORIZON-HLTH-2026-01-IND-03: Regulatory science to support translational development of patient-centred health technologies
Type
- Partner seeks Consortium/Coordinator
Similar opportunities
Project cooperation
Multiomics Tool for Chemoresistance
- Partner seeks Consortium/Coordinator
- DESTINATION 6: HORIZON-HLTH-2026-01-IND-03: Regulatory science to support translational development of patient-centred health technologies
- DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-03: Integrating New Approach Methodologies (NAMs) to advance biomedical research and regulatory testing
- DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-09: Multisectoral approach to tackle chronic non-communicable diseases: implementation research maximising collaboration and coordination with sectors and in settings beyond the healthcare system (GACD)
Gabriela Coronel
Health Researcher at IRCCS Azienda Ospedaliera Metropolitana, plesso Ospedale Policlinico San Martino
Genova, Italy
Project cooperation
Cancers AI - AI-based Multi-omics Platform for Precision Oncology
- Consortium/Coordinator seeks Partners
- DESTINATION 6: HORIZON-HLTH-2026-01-IND-03: Regulatory science to support translational development of patient-centred health technologies
- DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-03: Integrating New Approach Methodologies (NAMs) to advance biomedical research and regulatory testing
- DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-03: Advancing research on the prevention, diagnosis, and management of post-infection long-term conditions
- DESTINATION 4: HORIZON-HLTH-2026-01-CARE-01: Public procurement of innovative solutions for improving citizens' access to healthcare through integrated or personalised approaches
- DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-06: Support to European Research Area (ERA) action on accelerating New Approach Methodologies (NAMs) to advance biomedical research and testing of medicinal products and medical devices
- DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-09: Multisectoral approach to tackle chronic non-communicable diseases: implementation research maximising collaboration and coordination with sectors and in settings beyond the healthcare system (GACD)
Moshira Ghaleb
Founder & AI Researcher (Cancer AI / Digital Health) at AIMTech
Cairo, Egypt
Project cooperation
GeneCore: Advanced Transcriptomics (Single-cell/Spatial) & High-Throughput Screening Partner
- Partner seeks Consortium/Coordinator
- DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-03: Integrating New Approach Methodologies (NAMs) to advance biomedical research and regulatory testing
- DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-11: Understanding of sex and/or gender-specific mechanisms of cardiovascular diseases: determinants, risk factors and pathways
Lukáš Valihrach
Head of Core Facility at Institute of Biotechnology of the Czech Academy of Sciences
Vestec, Czech Republic